FeesSafety
Pluang+

Preliminary Phase 2 data show Rein Therapeutics' LTI-03 improves lung function trends in IPF patients, with topline results due 2027.

Company Fundamentals
16 Nov 2026, 14:30 WIB
GlobeNewsWire
View Source
Bullish
Preliminary Phase 2 data show Rein Therapeutics' LTI-03 improves lung function trends in IPF patients, with topline results due 2027.

Rein Therapeutics announced preliminary blinded data from its Phase 2 RENEW trial of LTI-03 in idiopathic pulmonary fibrosis (IPF) patients, showing 33% of evaluable patients improved lung function at 12 weeks. The trial, which is 75% enrolled with 90 patients randomized, also reported favorable safety with no serious adverse events linked to the drug. Financially, the company ended Q3 2026 with $36.5 million in cash, funding operations into early 2028. Rein plans to report unblinded topline data in 2027, which will clarify LTI-03's clinical benefits.

Rein Therapeutics reported preliminary Phase 2 data showing 33% of patients improved lung function at 12 weeks. For readers following the Health sector, here is Pluang's market snapshot as of Nov 16, 2026 18:12 WIB: out of 150 priced US Health stocks, 66 rose and 50 fell. Notable movers include AMRX at USD 20.94 down 2.06%, DYN at USD 17.50 up 1.98%, and RXRX at USD 3.13 down 1.73%.

More News

Nike faces scrutiny over cost-cutting ahead of first investor day since 2017

Nike faces scrutiny over cost-cutting ahead of first investor day since 2017

Nike is under pressure to clarify its cost-cutting plans as it prepares for its first investor day since 2017, scheduled for November 16–17. Despite efforts led by CEO Elliott Hill to turn the company around, management expects revenue to decline by ...

Market News
Bearish
55 minutes ago
Jackery and Every Electric launch North America's first plug-in virtual power plant for renters in NYC.

Jackery and Every Electric launch North America's first plug-in virtual power plant for renters in NYC.

Jackery and Every Electric have partnered to create North America's first plug-and-play virtual power plant (VPP) for renters and apartment residents, starting in New York City. This innovative system uses portable power stations plugged into standar...

Market News
Bullish
1 hour ago
P-1 AI names retired Brig. Gen. Matt Isler GM for Aerospace and Defense to boost AI engineering efforts.

P-1 AI names retired Brig. Gen. Matt Isler GM for Aerospace and Defense to boost AI engineering efforts.

P-1 AI has appointed retired Brigadier General Matt Isler as General Manager for its Aerospace and Defense division. Isler brings nearly 30 years of military and industry experience, including leadership roles at Northrop Grumman and startup DEFCON A...

Market News
Bullish
1 hour ago
Saputo renews share buyback plan to repurchase up to 10% of public shares by Nov 2027

Saputo renews share buyback plan to repurchase up to 10% of public shares by Nov 2027

Saputo Inc. has renewed its Normal Course Issuer Bid (NCIB), allowing it to repurchase up to 22.5 million common shares, representing 10% of its public float, from November 19, 2026, to November 18, 2027. This move reflects Saputo's strategy to retur...

Company Fundamentals
Bullish
2 hours ago
GitGuardian expands program to alert companies of leaked credentials, boosting enterprise cybersecurity worldwide.

GitGuardian expands program to alert companies of leaked credentials, boosting enterprise cybersecurity worldwide.

GitGuardian has launched the Enterprise Good Samaritan Program to identify and notify companies about high-impact leaked credentials that could expose their systems to attackers. Using AI and expert analysis, the program traces leaks to affected orga...

Market News
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App